CXCL16 and breast carcinoma: Using a breast cancer mouse model, Matsumura et al. observed that IR increased the secretion of C-X-C motif chemokine ligand 16 (CXCL-16), which could bind to C-X-C motif receptor (CXCR6) on th1 cells, activating CD8+ T cells.